Plasma amantadine concentrations in patients with Parkinson's disease.
about
Amantadine for dyskinesias in Parkinson's disease: a randomized controlled trialPros and cons of the tuberculosis drugome approach--an empirical analysisIntravenous amantadine for freezing of gait resistant to dopaminergic therapy: a randomized, double-blind, placebo-controlled, cross-over clinical trial.An eight-year clinic experience with clozapine use in a Parkinson's disease clinic setting.Antidepressant-like effects and possible mechanisms of amantadine on cognitive and synaptic deficits in a rat model of chronic stress.
P2860
Plasma amantadine concentrations in patients with Parkinson's disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Plasma amantadine concentrations in patients with Parkinson's disease.
@en
Plasma amantadine concentrations in patients with Parkinson's disease.
@nl
type
label
Plasma amantadine concentrations in patients with Parkinson's disease.
@en
Plasma amantadine concentrations in patients with Parkinson's disease.
@nl
prefLabel
Plasma amantadine concentrations in patients with Parkinson's disease.
@en
Plasma amantadine concentrations in patients with Parkinson's disease.
@nl
P2093
P1476
Plasma amantadine concentrations in patients with Parkinson's disease.
@en
P2093
P304
P356
10.1016/J.PARKRELDIS.2008.08.005
P577
2008-09-27T00:00:00Z